<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722069</url>
  </required_header>
  <id_info>
    <org_study_id>2383/2014</org_study_id>
    <nct_id>NCT03722069</nct_id>
  </id_info>
  <brief_title>Dietary Sodium Intake in Acute Heart Failure</brief_title>
  <acronym>SODIC</acronym>
  <official_title>A Normal Sodium Diet Preserves Serum Sodium Levels During Treatment of Acute Decompensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is design to assess two levels of dietary sodium intake in the treatment of
      patients with Acute Decompensated Heart Failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aim at assessing the effect of two levels of dietary sodium intake during seven
      days in hospitalized patients with Acute Decompensated Heart Failure. It is a prospective
      cohort, randomized, with blinded intervention groups: low sodium diet (the patients will
      receive 3 g/day of dietary sodium intake), and normal sodium diet (patients will receive 7
      g/day of dietary sodium intake). Besides that, both groups will be submitted to a fluid
      intake limited to 1000 ml/day.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 20, 2014</start_date>
  <completion_date type="Actual">September 20, 2017</completion_date>
  <primary_completion_date type="Actual">August 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum sodium level at day 7</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of serum sodium between the groups in the final evaluation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of hyponatremia</measure>
    <time_frame>on day 7</time_frame>
    <description>The detection of serum level of sodium bellow 135 mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body weight</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of body weight between the initial and final values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum levels of NT-proBNP</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of NT-proBNP between the initial and final values, and between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic, diastolic and mean blood pressure</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of blood pressure between the initial and final values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of heart rate between the initial and final values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum levels of creatinine</measure>
    <time_frame>7 days</time_frame>
    <description>The difference of the absolute value of creatinine between the initial and final values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients exhibiting worsening renal function (defined as increased serum creatinine&gt; 0,3 mg / dL)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dyspnea sense</measure>
    <time_frame>7 days</time_frame>
    <description>Using a visual anologic scale, with values between 0 and 10, where the minimum 0 is the greatest lack of air (worse) and the maximum 10 is the complete breath (better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in well-being sense</measure>
    <time_frame>7 days</time_frame>
    <description>Using a visual anologic scale, with values between 0 and 10, where the minimum 0 is the worse you ever felt (worse) and the maximum 10 is feel better than already (better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diuretic dosage and other drugs to ADHF during intervention period</measure>
    <time_frame>7 days</time_frame>
    <description>What drugs will be used and the quantities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of hospital readmission</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of mortality after discharge</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Heart Failure; With Decompensation</condition>
  <condition>Heart Failure，Congestive</condition>
  <arm_group>
    <arm_group_label>Low sodium diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>22 patients were randomized to receive 3 g/day of dietary sodium chloride and a limit of fluid intake of 1000 ml/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal sodium diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>22 patients were randomized to receive 7 g/day of dietary sodium chloride and a limit of fluid intake of 1000 ml/day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low sodium diet</intervention_name>
    <description>Patients received low sodium diet (3g of sodium chloride/day) and a limit of fluid intake of 1000 ml/day.</description>
    <arm_group_label>Low sodium diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal sodium diet</intervention_name>
    <description>Patients received normal sodium diet (7g of sodium chloride/day) and a limit of fluid intake of 1000 ml/day.</description>
    <arm_group_label>Normal sodium diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Acute Decompensated Heart Failure diagnosis, filling the Framingham
             diagnostic criteria, hospitalized at campus Hospital das Clínicas of Ribeirão Preto.

        Exclusion Criteria:

          -  Creatinine clearance &lt;30 ml / min / 1.73 m²;

          -  Acute coronary syndrome;

          -  Stroke;

          -  Dementia;

          -  Severe cognitive impairment;

          -  Cancer;

          -  Decompensated diabetes mellitus;

          -  Severe liver disease;

          -  Septic shock or with clinical signs of sepsis;

          -  Chronic renal parenchymal disease prior to the start of the study;

          -  ADHF secondary to acute renal failure;

          -  Nutritional disorders or those who are unable to take oral intake because of vomiting,
             dysphagia or gastroenteritis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus V Simões, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical School of Ribeirao Preto, University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clínicas de Ribeirão Preto</name>
      <address>
        <city>Ribeirao Preto</city>
        <state>Sao Paulo</state>
        <zip>14048-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med. 2013 Jun 24;173(12):1058-64. doi: 10.1001/jamainternmed.2013.552.</citation>
    <PMID>23689381</PMID>
  </reference>
  <reference>
    <citation>Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008 Feb;114(3):221-30.</citation>
    <PMID>17688420</PMID>
  </reference>
  <reference>
    <citation>Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009 Jan 1;103(1):93-102. doi: 10.1016/j.amjcard.2008.08.043. Epub 2008 Oct 17.</citation>
    <PMID>19101237</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2018</study_first_posted>
  <last_update_submitted>October 29, 2018</last_update_submitted>
  <last_update_submitted_qc>October 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Camila Godoy Fabricio</investigator_full_name>
    <investigator_title>Master</investigator_title>
  </responsible_party>
  <keyword>Hyponatremia</keyword>
  <keyword>Sodium Intake</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Sodium Chloride</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

